As the chief of the Infant Botulism Treatment and Prevention Program for the California Department of Public Health, Steve Arnon, MD, MPH, dedicated 45 years of his career to diagnosing, researching and treating infant botulism. He is credited with saving thousands of lives in California and around the world.
Susan Dabalos Anderson tells the story of her now-grown son receiving BabyBIG as an infant to treat baby botulism.
Kristopher Paolino, MD, is an assistant professor of medicine and assistant professor of microbiology and immunology at Upstate University Hospital in Syracuse, N.Y. He previously worked for the Walter Reed Army Medical Center and the Walter Reed Army Institute of Research in Washington, D.C. His research interests include vaccine development, Lyme disease, neglected tropical diseases and malaria.
Healthcare delivery continues to evolve as demand for care quality grows, but the challenges of caring for loved ones who live long distances away are not as formidable due to an expanding number of tools, services and resources.
As a menopause educator and founder of Miss Menopause UK, this patient's journey inspired her to help others navigate the ups and downs of menopause.
The founder of Evolved Science, Dr. Schwartz is a pioneer in the use of bioidentical hormone replacement therapy (BHRT) for preventing illness and recognizing its direct link to overall wellness and interconnection with diet, sleep and stress management.
The healthcare industry continues to evolve and adapt to meet the needs of patients and improve their care — and it's increasingly using AI to do it.
It’s alarming that despite vaccines’ proven success, some 40,000 to 50,000 adults die from vaccine-preventable diseases each year. Even diseases that were once-eradicated are making a comeback.
Now that safe and effective RSV vaccines are finally available, more evidence of their direct health benefits in older Americans will be forthcoming. It is likely as well that FDA will eventually expand the marketing approvals of these vaccines to include adults under age 60 with chronic conditions demonstrated to importantly increase the risk of RSV-associated LRTD and hospitalization.
Mark Bloch, MD, has been working in the field of HIV medicine since 1983, and he is now the director of clinical research at Holdsworth House in Sydney, Australia. Dr. Bloch is actively involved in research surrounding HIV and sexually transmitted diseases.
